JPRN-jRCT2080221492未知3 期
Phase 3 Clinical Study of S-4661 in pediatric patients with meningitis and other bacterial infections
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Hospitalized pediatrics from 28 days to less than 16 years with meningitis and other bacterial infections requiring intravenous antibiotic (carbapenem) therapy, etc.
排除标准
- •Patients with a previous history of anaphylactic reactions or serious hypersensitivity to doripenem
- •Patients with serious hepatic impairment or patients with serious renal impairment
研究者
相似试验
未知
2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity DisorderJPRN-jRCT2080222070SHIONOGI & CO., LTD.
未知
2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity Disorder -Long term Extension StudyAttention-deficit/Hyperactivity DisorderJPRN-jRCT2080222071SHIONOGI & CO., LTD.
招募中
3 期
A Phase 3 study of S-217622 in pediatric participantsSARS-CoV-2 infectionJPRN-jRCT2031230140Gomez Juan Carlos120
未知
3 期
Phase III study of KW-6485P (6485P-004)JPRN-jRCT2080221158Kyowa Hakko Kirin Co., Ltd.60
未知
3 期
Phase III study of T-3262G15% in the pediatric patients with mycoplasma pneumoniaMycoplasma pneumoniaJPRN-jRCT2080222224Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)